Aarthi A. Jayanthan, Ph.D.
Affiliations: | 2014 | University of Calgary, Calgary, Alberta, Canada |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Aarthi Jayanthan"Parents
Sign in to add mentor| Aru Narendran | grad student | 2014 | University of Calgary | |
| (Aurora Kinase Inhibition as a Novel Therapeutic Approach for the Treatment of Refractory Pediatric and Infant Leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sharma R, Incoronato A, Zhang C, et al. (2023) Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia. Journal of Pediatric Hematology/Oncology. 45: e750-e756 |
| Kosnopfel C, Wendlinger S, Niessner H, et al. (2023) Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion. Journal of Experimental & Clinical Cancer Research : Cr. 42: 175 |
| Banderali U, Jain M, Thakur S, et al. (2021) The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway. Current Eye Research. 1-10 |
| Thakur S, Ruan Y, Jayanthan A, et al. (2021) Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib. Current Cancer Drug Targets |
| Huynh MM, Pambid MR, Jayanthan A, et al. (2020) The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials. Expert Opinion On Investigational Drugs |
| Thakur S, Ruan Y, Zhang C, et al. (2020) Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells. Cancer Gene Therapy |
| Beeram M, Wang JS, Mina LA, et al. (2020) First-in-human phase I/Ib multicenter, open-label dose escalation study to assess safety and tolerability of PMD-026 in patients with metastatic breast cancer with expansion in metastatic triple negative breast cancer. Journal of Clinical Oncology. 38: TPS1110-TPS1110 |
| Jayanthan A, Hofmann B, Meier-Stephenson V, et al. (2019) Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells. Journal of Pediatric Hematology/Oncology |
| Swift L, Jayanthan A, Ruan Y, et al. (2018) Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib. Targeted Oncology |
| Singh A, Meier-Stephenson V, Jayanthan A, et al. (2016) In Vitro Sensitivity Profiling Of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library To Identify Agents For Future Therapeutic Studies. Current Cancer Drug Targets |